Nusinersen Treatment in Adults With Spinal Muscular AtrophyTina Duong, Connie Wolford, Michael McDermott et al.|Neurology Clinical Practice|2021Cited by 77
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trialThomas O. Crawford, Barbara Steinborn, Nancy L. Kuntz et al.|The Lancet Neurology|2025Cited by 22